Acidification of the Osteoclastic Resorption Compartment Provides Insight into the Coupling of Bone Formation to Bone Resorption

Autor: Jens Bollerslev, Kim Henriksen, Jeppe Gram, Sophie Schaller, Anne-Marie Heegaard, Mette G Sørensen, Thomas J. Martin, Morten Hanefeld Dziegiel, Palle Christophersen, Morten A. Karsdal, Claus Christiansen
Rok vydání: 2005
Předmět:
Male
Time Factors
Bone density
Cathepsin K
Osteoclasts
Tetrazoles
Rats
Sprague-Dawley

Bone Density
Cells
Cultured

Tartrate-resistant acid phosphatase
biology
Chemistry
Middle Aged
Immunohistochemistry
Resorption
Isoenzymes
Original Research Paper
Phenotype
medicine.anatomical_structure
Osteopetrosis
Osteocalcin
Female
Macrolides
Adult
musculoskeletal diseases
medicine.medical_specialty
Acid Phosphatase
Models
Biological

Bone and Bones
Bone resorption
Pathology and Forensic Medicine
Chloride Channels
Osteoclast
Internal medicine
Oxazines
medicine
Animals
Humans
Bone Resorption
Family Health
Cathepsin
Dose-Response Relationship
Drug

Tartrate-Resistant Acid Phosphatase
Macrophage Colony-Stimulating Factor
Macrophages
Phenylurea Compounds
Ovary
Cathepsins
Rats
Endocrinology
Xanthenes
Mutation
biology.protein
Indicators and Reagents
Zdroj: The American Journal of Pathology. 166:467-476
ISSN: 0002-9440
Popis: Patients with defective osteoclastic acidification have increased numbers of osteoclasts, with decreased resorption, but bone formation that remains unchanged. We demonstrate that osteoclast survival is increased when acidification is impaired, and that impairment of acidification results in inhibition of bone resorption without inhibition of bone formation. We investigated the role of acidification in human osteoclastic resorption and life span in vitro using inhibitors of chloride channels (NS5818/NS3696), the proton pump (bafilomycin) and cathepsin K. We found that bafilomycin and NS5818 dose dependently inhibited acidification of the osteoclastic resorption compartment and bone resorption. Inhibition of bone resorption by inhibition of acidification, but not cathepsin K inhibition, augmented osteoclast survival, which resulted in a 150 to 300% increase in osteoclasts compared to controls. We investigated the effect of inhibition of osteoclastic acidification in vivo by using the rat ovariectomy model with twice daily oral dosing of NS3696 at 50 mg/kg for 6 weeks. We observed a 60% decrease in resorption (DPYR), increased tartrate-resistant acid phosphatase levels, and no effect on bone formation evaluated by osteocalcin. We speculate that attenuated acidification inhibits dissolution of the inorganic phase of bone and results in an increased number of nonresorbing osteoclasts that are responsible for the coupling to normal bone formation. Thus, we suggest that acidification is essential for normal bone remodeling and that attenuated acidification leads to uncoupling with decreased bone resorption and unaffected bone formation.
Databáze: OpenAIRE